Recruiting Trials

tuberculosis

TB043 Tuberculosis Study – A BCG challenge study in healthy adults to help develop TB vaccines.  If you are aged 18-50, in good health, and have never received the BCG vaccine, you may be eligible to participate.  The study involves 9-11 visits over a period of around 6 months. Participants will be reimbursed for their time and travel from £705 to £750. Click here for more information.

RIFT VALLEY FEVER

RVF001 - A phase I study to determine the safety and immunogenicity of the Rift Valley Fever (RVF) vaccine in healthy adult participants.  If you are aged 18-50 and are in good health, you may be eligible to participate.  The trial will involve 8 visits over a period of 3 months and participants will receive around £370 on completion of the study. Click here for more information.

Zika Vaccine 

ZIKA001 - A phase I study to determine the safety and immunogenicity of the candidate Zika Virus (ZIKV) vaccine ChAdOx1 Zika in healthy adult volunteers. If you are aged 18-50 and are in good health, you may be eligible to participate. The trial will involve 9 visits over a period of 6 months and participants will receive up to £415 on completion of the study. Click here for more information.

COVID-19 Vaccine development

For information about COV001 and COV002 COVID-19 Oxford Vaccine studies, please visit: https://covid19vaccinetrial.web.ox.ac.uk. Recruitment for these studies is now complete.